Mental Health Clinics in Bowdon, GA Accepting Medicare
1 Mental Health Clinics found. Showing 1 - 1
 Kidspeace National Centers Of Georgia, Inc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 101 Kidspeace Dr, Bowdon, GA 30108 Phone: 770-437-7200 Fax: 770-258-9128 |
News Archive
Johns Hopkins researchers find ways to curb common and deadly hospital-acquired infections
For some hospital patients, going on a ventilator is often the difference between life and death. About 800,000 hospital patients undergo mechanical ventilation each year in the United States due to a variety of illnesses or conditions, such as a brain injury, stroke or pneumonia.
Thinning of right hemisphere in brain a marker for familial form of depression
Findings from one of the largest-ever imaging studies of depression indicate that a structural difference in the brain - a thinning of the right hemisphere - appears to be linked to a higher risk for depression, according to new research at Columbia University Medical Center and the New York State Psychiatric Institute.
Data on Puredel's Ossulin to be presented at the San Francisco Diabetes Technology Meeting
The first public data on Ossulin™ a new oral insulin product, will be presented today at the 9th Annual Diabetes Technology Meeting in San Francisco, CA. Ossulin™ is being developed by Puredel Limited, a joint-venture between the European pharmaceutical specialty company CM&D Pharma Limited and Natreon Inc., New Brunswick, NJ., developers of the proprietary delivery platform.
Positive results from CrystalGenomics' CG100649 Phase 2b OA study
CrystalGenomics, Inc., a biopharmaceutical company headquartered in Korea, has just announced positive results from the Phase 2b osteoarthritis (OA) study of the CG100649, CrystalGenomics' next-generation NSAID candidate.
CorMedix completes enrollment in CRMD001 Phase II trial for treatment of acute kidney injury
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiorenal disease, announced it successfully completed patient enrollment in its phase II Contrast-Induced Acute Kidney Injury study with its oral drug candidate CRMD001.
› Verified 8 days ago